TRC150094, a Novel Mitochondrial Modulator, Reduces Cardio-Metabolic Risk as an Add-On Treatment: a Phase-2, 24-Week, Multi-Center, Randomized, Double-Blind, Clinical Trial

TRC150094, a Novel Mitochondrial Modulator, Reduces Cardio-Metabolic Risk as an Add-On Treatment: a Phase-2, 24-Week, Multi-Center, Randomized, Double-Blind, Clinical Trial

Deepa Joshi,1 Prashant GJ,1 Shohini Ghosh,1 Anookh Mohanan,1 Shashank Joshi,2 Viswanathan Mohan,3 Subhankar Chowdhury,4 Chaitanya Dutt,1 Nikhil Tandon5 1Torrent Pharmaceuticals Ltd., Ahmedabad, Gujarat, India; 2Lilavati Hospital, Mumbai, India; 3Dr. Mohan’s Diabetes Specialities Centre (Madras Diabe...

Full description

Bibliographic Details
Main Authors:	Joshi D, GJ P, Ghosh S, Mohanan A, Joshi S, Mohan V, Chowdhury S, Dutt C, Tandon N
Format:	Article
Language:	English
Published:	Dove Medical Press 2022-02-01
Series:	Diabetes, Metabolic Syndrome and Obesity
Subjects:	cardiometabolic-based chronic disease mitochondrial modulator type 2 diabetes non-hdl cholesterol hypertension dyslipidemia.
Online Access:	https://www.dovepress.com/trc150094-a-novel-mitochondrial-modulator-reduces-cardio-metabolic-ris-peer-reviewed-fulltext-article-DMSO

Similar Items

Management of triglycerides, non-high density lipoprotein cholesterol and high density lipoprotein cholesterol
by: Geevar Zachariah
Published: (2024-03-01)

Low HDL-cholesterol among HIV-1 infected and HIV-1 uninfected individuals in Nairobi, Kenya
by: Anne Njoroge, et al.
Published: (2017-06-01)

Elevated non-high-density lipoprotein cholesterol corresponds to a high risk of nephrolithiasis in children
by: Meiyuan Chen, et al.
Published: (2020-08-01)

Heritability and Genome-Wide Association Study of Plasma Cholesterol in Chinese Adult Twins
by: Hui Liu, et al.
Published: (2018-11-01)

Pediatric dyslipidemia in a minority mostly-immigrant inner city population
by: Matthias Manuel, et al.
Published: (2019-08-01)

Lipid profile in girls with precocious puberty: a systematic review and meta-analysis
by: Mei Jiang, et al.
Published: (2023-10-01)

Update on the clinical utility of fenofibrate in mixed dyslipidemias: mechanisms of action and rational prescribing
by: Michel Farnier
Published: (2008-10-01)

Variations in high density cholesterol levels based on apolipoprotein E variant and exercise type
by: Huan-Cheng Chang, et al.
Published: (2023-06-01)

ABNORMALITY OF LIPID METABOLISM IN PATIENTS WITH DIABETES MELLITUS TYPE 1 AND POOR GLYCEMIC CONTROL WITH AND WITHOUT DIABETIC MICROANGIOPATHIES
by: V. S. Syomshchikov, et al.
Published: (2016-11-01)

Lower than average HDL cholesterol efflux capacity in Lithuanian population
by: Sandra Kutkiene, et al.
Published: (2019-10-01)

Niacin: an old lipid drug in a new NAD+ dress
by: Mario Romani, et al.
Published: (2019-04-01)

Skeletal Muscle Mass is Associated with HDL Cholesterol Levels and the Ratio of LDL to HDL Cholesterol in Young Men: A Pilot Study
by: Minje Ji, et al.
Published: (2022-08-01)

Angiogenin Levels and Their Association with Cardiometabolic Indices Following Vitamin D Status Correction in Saudi Adults
by: Ghadeer M. Aldawsari, et al.
Published: (2022-02-01)

Potential Therapeutic Effects of Tali Bamboo Leaf Tea (Gigantochloa apus) on Lipid Profile of Rats With Metabolic Syndrome
by: Ani Rosa Putri Ayu Mujayanah, et al.
Published: (2023-12-01)

Interplay between Cholesterol, SREBPs, MicroRNA-33 in Dyslipidemia
by: Abdul Hafeez Kandhro
Published: (2016-06-01)

Determinants of Lipid Parameters in Patients without Diagnosed Cardiovascular Disease—Results of the Polish Arm of the EUROASPIRE V Survey
by: Jakub Ratajczak, et al.
Published: (2023-04-01)

Living in the Southern Hemisphere: Metabolic Syndrome and Its Components in Amazonian Riverine Populations
by: Gabriela P. Arrifano, et al.
Published: (2021-08-01)

Circulating Lipoproteins in Subjects with Morbid Obesity Undergoing Bariatric Surgery with Gastric Bypass or Sleeve Gastrectomy
by: Jan O. Aaseth, et al.
Published: (2022-06-01)

Effects of anthocyanin supplementation on blood lipid levels: a systematic review and meta-analysis
by: Hwan-Hee Jang, et al.
Published: (2023-08-01)

Effect of fenugreek (Trigonella foenum-graecum) seed powder on lipid profile: A single blind placebo controlled study
by: Amit A, et al.
Published: (2023-04-01)

Monocyte/high-density lipoprotein cholesterol, neutrophil/high-density lipoprotein cholesterol, and lymphocyte/high-density lipoprotein cholesterol ratios as new inflammatory markers in rosacea
by: Bülent Nuri Kalaycı
Published: (2023-06-01)

Comparative Study of Lipid Profile among Young Smokers and Nonsmokers in South Indian Population
by: Abhinav Kumar, et al.
Published: (2023-01-01)

High-density lipoprotein cholesterol efflux capacity in patients with obstructive sleep apnea and its relation with disease severity
by: Reza Fadaei, et al.
Published: (2022-11-01)

Cardiovascular risk profile of patients with atherogenic dyslipidemia in middle age Lithuanian population
by: Sandra Kutkiene, et al.
Published: (2018-09-01)

Correlation between lipid profile and C-reactive protein in children with nephrotic syndrome
by: Kurnia Dwi Astuti, et al.
Published: (2015-03-01)

Body Mass Index an anthropometric measure associated with TG / HDL Index, a novel cardio-metabolic risk factor
by: Pamela Vasquez, et al.
Published: (2020-09-01)

Is non-high-density lipoprotein associated with metabolic syndrome? A systematic review and meta-analysis
by: Parham Mardi, et al.
Published: (2022-09-01)

Cross-sectional study of pattern of Dyslipidemia and Prevalence of Atherogenic Diabetic Dyslipidemia in newly detected Diabetic patients
by: Vinay Krishnamurthy, et al.
Published: (2019-10-01)

Positive association between the ratio of triglycerides to high-density lipoprotein cholesterol and diabetes incidence in Korean adults
by: Joungyoun Kim, et al.
Published: (2021-09-01)

GIP receptor agonism improves dyslipidemia and atherosclerosis independently of body weight loss in preclinical mouse model for cardio-metabolic disease
by: Stephan Sachs, et al.
Published: (2023-08-01)

Triglyceride to high-density lipoprotein cholesterol and low-density lipoprotein cholestrol to high-density lipoprotein cholesterol ratios are predictors of cardiovascular risk in Iranian adults: Evidence from a population-based cross-sectional study
by: Karimollah Hajian-Tilaki, et al.
Published: (2020-01-01)

Low HDL, the most common type of dyslipidemia in Birjand studies: it is necessary to study: Letter to Editor
by: Toba kazemi, et al.
Published: (2017-09-01)

New perspectives in cardiovascular risk reduction: focus on HDL
by: Stefania Paolillo, et al.
Published: (2015-11-01)

Longitudinal Trends in Severe Dyslipidemia in the Czech Population: The Czech MONICA and Czech Post-MONICA Study
by: Renata Cífková, et al.
Published: (2023-07-01)

How good can HDL Cholesterol be? Recent Evidence and way forward for Clinical Practice
by: Sikandar Hayat Khan
Published: (2023-06-01)

Apolipoprotein B and non-high-density lipoprotein cholesterol reveal a high atherogenicity in individuals with type 2 diabetes and controlled low-density lipoprotein-cholesterol
by: Liliana Fonseca, et al.
Published: (2020-06-01)

Association of the TG/HDL-C and Non-HDL-C/HDL-C Ratios with Chronic Kidney Disease in an Adult Chinese Population
by: Jia Wen, et al.
Published: (2017-12-01)

Whole-exome sequencing reveals damaging gene variants associated with hypoalphalipoproteinemia
by: Weilai Dong, et al.
Published: (2022-06-01)

TRC150094 attenuates progression of nontraditional cardiovascular risk factors associated with obesity and type 2 diabetes in obese ZSF1 rats
by: Shitalkumar P Zambad, et al.
Published: (2011-01-01)

Primary dyslipidemia and cardiometabolic risk: potential of pitavastatin.
by: A. E. Berezin, et al.
Published: (2015-06-01)